Clinical trials
Recruiting Mucopolysaccharidosis IV trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Innoskel | 1 |
| Institut National de la Santé Et de la Recherche Médicale, France | 1 |
| QED Therapeutics, a BridgeBio company | 1 |
| University Hospital, Angers | 1 |
| University Hospital, Montpellier | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mucopolysaccharidosis IV | 5 |
| Bone Diseases | 2 |
| Dwarfism | 2 |
| Genetic Diseases, Inborn | 1 |
| Mucopolysaccharidosis I | 1 |
| Mucopolysaccharidosis II | 1 |
| Mucopolysaccharidosis III | 1 |
| Mucopolysaccharidosis VI | 1 |
| Mucopolysaccharidosis VII | 1 |
| Multiple Sulfatase Deficiency Disease | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.